Quick Answer
TherapeuticsMD, Inc. reported Revenue (ASC 606) of $69.96 million for fiscal year 2022.
TherapeuticsMD, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2022 | $69.96M | +2619.1% |
| 2021 | $2.57M | -96.0% |
| 2020 | $64.87M | +30.7% |
| 2019 | $49.65M | +208.4% |
| 2018 | $16.10M | -4.0% |
| 2017 | $16.78M | -13.3% |
| 2016 | $19.36M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$53.0K | -115.0% | -112.1% |
| June 30, 2023 | $437.0K | +25.6% | +5.0% |
| March 31, 2023 | $416.0K | -40.1% | +17.5% |
| September 30, 2022 | $354.0K | -98.6% | +1.7% |
| June 30, 2022 | $348.0K | -98.5% | -49.9% |
| March 31, 2022 | $695.0K | -96.5% | -97.3% |
| September 30, 2021 | $25.41M | +31.4% | +10.5% |
| June 30, 2021 | $23.00M | +114.9% | +15.8% |
- TherapeuticsMD, Inc. showed an increase of +2619.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2022 period, TherapeuticsMD, Inc.’s revenue (asc 606) has grown by 261.4% (from $19.36 million to $69.96 million).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 7, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: